InvestorsHub Logo
Followers 2
Posts 436
Boards Moderated 0
Alias Born 01/14/2014

Re: None

Friday, 12/30/2016 4:33:02 AM

Friday, December 30, 2016 4:33:02 AM

Post# of 807
Trovax

HTTP://immunosym.org/program/poster-sessions
Poster Session A: Humoral Immunity for Diagnosis and Therapy, Immune Checkpoints and Stimulatory Receptors, and Therapies Targeting T cells

Thursday, February 23 2017: 11:30 AM-1:00 PM and 5:30 PM-6:30 PM

BOARD H3
MVA-5T4 immunotherapy and low-dose cyclophosphamide for advanced colorectal cancer (TaCTiCC): An open-label, randomized phase I/II trial. (Abstract 154)
First Author: Martin Scurr

HTTP://medicine.caerdydd.ac.uk/media/filer_public/85/a0/85a0407a-e02a-4086-bfb3-6fc902eb7ecc/science_in_practice_infection__immunity_2014.pdf